CD19 and systemic lupus erythematosus: Patients with severe, treatment-refractory, and active SLE received autologous CD19-CAR T‐cell therapy (MB19.1, Miltenyi Biotec, Bergisch Gladbach, Germany) as part of an individual compassionate treatment attempt and are regularly followed up at our center.